These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32521182)

  • 21. Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys.
    Behling EB; Sendão MC; Francescato HD; Antunes LM; Costa RS; Bianchi Mde L
    Pharmacol Rep; 2006; 58(4):526-32. PubMed ID: 16963799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
    Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
    Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa.
    Paken J; Govender CD; Pillay M; Ayele BT; Sewram V
    BMC Cancer; 2021 Jul; 21(1):822. PubMed ID: 34271863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Honey and Royal Jelly against Cisplatin-Induced Nephrotoxicity in Patients with Cancer.
    Osama H; Abdullah A; Gamal B; Emad D; Sayed D; Hussein E; Mahfouz E; Tharwat J; Sayed S; Medhat S; Bahaa T; Abdelrahim MEA
    J Am Coll Nutr; 2017 Jul; 36(5):342-346. PubMed ID: 28548561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the Effectiveness of Quercetin on Cisplatin-Induced Ototoxicity in Rats.
    Gündoğdu R; Erkan M; Aydın M; Sönmez MF; Vural A; Kökoğlu K; Karabulut D; Şahin Mİ
    J Int Adv Otol; 2019 Aug; 15(2):229-236. PubMed ID: 31287434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quercetin inhibits proliferation and increases sensitivity of ovarian cancer cells to cisplatin and paclitaxel.
    Maciejczyk A; Surowiak P
    Ginekol Pol; 2013 Jul; 84(7):590-5. PubMed ID: 24032269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents.
    Santos NAGD; Ferreira RS; Santos ACD
    Food Chem Toxicol; 2020 Feb; 136():111079. PubMed ID: 31891754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.
    Pabla N; Dong G; Jiang M; Huang S; Kumar MV; Messing RO; Dong Z
    J Clin Invest; 2011 Jul; 121(7):2709-22. PubMed ID: 21633170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective role of misoprostol against cisplatin-induced ototoxicity.
    Doğan M; Polat H; Yaşar M; Kaya A; Bayram A; Şenel F; Özcan İ
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3685-3692. PubMed ID: 27052552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of chemotherapy with platinum compounds.
    Walker EM; Walker SM
    Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding platinum-induced ototoxicity.
    Langer T; am Zehnhoff-Dinnesen A; Radtke S; Meitert J; Zolk O
    Trends Pharmacol Sci; 2013 Aug; 34(8):458-69. PubMed ID: 23769626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.
    Lee CK; Son SH; Park KK; Park JH; Lim SS; Kim SH; Chung WY
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):48-54. PubMed ID: 18484961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia.
    Spagnuolo C; Russo M; Bilotto S; Tedesco I; Laratta B; Russo GL
    Ann N Y Acad Sci; 2012 Jul; 1259():95-103. PubMed ID: 22758641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
    Watanabe H; Kanno H
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
    Treskes M; van der Vijgh WJ
    Cancer Chemother Pharmacol; 1993; 33(2):93-106. PubMed ID: 8261581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin-cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects.
    Hussain Y; Islam L; Khan H; Filosa R; Aschner M; Javed S
    Phytother Res; 2021 Dec; 35(12):6514-6529. PubMed ID: 34347326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.
    Bokemeyer C; Fels LM; Dunn T; Voigt W; Gaedeke J; Schmoll HJ; Stolte H; Lentzen H
    Br J Cancer; 1996 Dec; 74(12):2036-41. PubMed ID: 8980410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents.
    Chan MM; Fong D; Soprano KJ; Holmes WF; Heverling H
    J Cell Physiol; 2003 Jan; 194(1):63-70. PubMed ID: 12447990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.